- |
Phenotype and genotype analysis |
- |
Clinical manifestation |
- |
Type and nature of treatment (eg. on-demand/prophylaxis) |
- |
Treatment-related complications |
|
|
In order to safeguard privacy, this second form have to be sent to us by ordinary or priority mail. |
|
All data will be registered in the RBDD and statistically evaluated. Participants will be able to access results displayed by the reports on the web site. All reports are automatically updated. The generation of specific, on-request reports containing the desired information (if available), will be also possible. |
|
To ensure privacy the sensitive data will be displayed only by operators. |
|
Here you can find documents regarding ethical and safety-related issues that we are currently using |
|
"Ethical issues" |
"Programmatic Document of Security" |
"Informed consent" |
|
Many thanks for your collaboration. Please do not hesitate to contact us by phone or by email in case any further details are required. |
|
Yours sincerely,
Flora Peyvandi MD, PhD |
|
Angelo Bianchi Bonomi
Hemophilia and Thrombosis Centre
IRCSS Maggiore Hospital, Mangiagalli and Regina Elena Foundation
Luigi Villa Foundation
Department of Medicine and Medical Specialities, University of Milan
Milan, Italy |